or search on
|Title:||New Challenges in Psycho‐Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications|
|Authors:||Chambers S; Hyde MK; Smith DP; Hughes S; Yuill S; Egger S; O'Connell DL; Stein K; Frydenberg M; Wittert G; Dunn J|
|Categories:||Cancer Type - Prostate Cancer|
Cancer Control, Survivorship, and Outcomes Research - Patient Care and Survivorship Issues
|Page number start:||871|
|Page number end:||1056|
|Abstract:||Invited Editorial. The medical and social context of prostate cancer (PCa) has changed dramatically since the introduction of PSA testing for early detection in the late 1980s,1 leading to a peak in incidence in the developed world in the 1990s and again a decade later.2 Since that time, novel PCa treatments have rapidly emerged in the radiation and medical oncology field, as well as surgical advances.3 The recent emergence of active surveillance for low‐risk disease has further expanded possible treatment approaches.4 Market forces from consumers, clinicians, and the therapeutic industry have driven changes in clinical and surgical management and treatment; however, psycho‐oncological research and survivorship care arguably has lagged behind. Specifically, although men are surviving longer, they may not be surviving well. In 2012, there were over 1.1 million incident cases of PCa diagnosed and more than 300 000 deaths worldwide.5 Five‐year prevalence estimates suggest that there are over 3.8 million PCa survivors globally6 with this expected to increase rapidly in future.7 The challenges we face in meeting the needs of these men and their families into the future are vast. Up to 75% of men treated for localised PCa report severe and persistent treatment side‐effects including sexual dysfunction, poor urinary or bowel function.8 Psychosocial concerns are prevalent with 30%‐50% of PCa survivors reporting unmet sexuality, psychological, and health system and information needs9, 10 and 10%‐23% of men clinically distressed.11 Risk of suicide is increased after PCa diagnosis12, 13 and can persist for a decade or more.14 In the longer term, 30%‐40% of PCa survivors report persistent health‐related distress, worry, low mood15 and diminished quality of life (QoL).16 Partners of PCa survivors also experience ongoing psychological concerns and changes in their intimate relationships17; with these impacts driven in part by the man's level of distress, sexual concerns and physical QoL.18 In 2011, our group published the first criterion‐based systematic review of psychosocial interventions for men with PCa and their partners.19 We concluded that group cognitive‐behavioural interventions and psycho‐education appeared to be helpful in promoting better psychological adjustment and QoL for men with localised PCa, and coping skills training for female partners may improve their QoL. However, data were limited by inconsistent results and low study quality. In response to the increasing burden of PCa, uncertainties about optimal psychosocial care, and additions to the literature, we updated and extended this review with the intent of determining benefit and acceptability, and considering intervention content and format. In brief, we considered the range of psychosocial and psychosexual interventions that may be optimal, and for whom.|
|Division:||Cancer Research Division|
|Funding Body:||NHMRC Centre for Research Excellence in Prostate Cancer Survivorship. Grant Number: APP1116334. DPS was supported by a grant from Cancer Institute NSW (#15/CDF/1-10).|
|Appears in Collections:||Research Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.